Evidence map›Paper›PMID 34535488›Full record

ArticleBMJ open2021

Effectiveness of a customised mobile phone text messaging intervention supported by data from activity monitors for improving lifestyle factors related to the risk of type 2 diabetes among women after gestational diabetes: protocol for a multicentre randomised controlled trial (SMART MUMS with smart phones 2).

Simone Marschner, Clara Chow, Aravinda Thiagalingam, David Simmons, Mark McClean, Dharmintra Pasupathy, Ben J Smith, Victoria Flood, Suja Padmanabhan, Sarah Melov and 2 more

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Simone MarschnerWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia simone.marschner@sydney.edu.au.ORCID 0000-0002-5484-9144
Clara ChowWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-4693-0038
Aravinda ThiagalingamWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7763-7806
David SimmonsMacarthur Clinical School, Western Sydney University, Penrith South, New South Wales, Australia.ORCID 0000-0003-0560-0761
Mark McCleanDepartment of Diabetes and Endocrinology, Westmead Hospital, Westmead, New South Wales, Australia.
Dharmintra PasupathyDiscipline of Obstetrics, Gynaecology and Neonatology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-6722-1006
Ben J SmithWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-6227-5566
Victoria FloodWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-5310-7221
Suja PadmanabhanDiscipline of Obstetrics, Gynaecology and Neonatology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-5418-3699
Sarah MelovDiscipline of Obstetrics, Gynaecology and Neonatology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7569-1016
Cellina ChingWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-2278-8877
N Wah CheungWestmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-6323-8006
The University of Sydney · AUBlacktown & Mount Druitt Hospital · AUCamden and Campbelltown Hospitals · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGestational diabetes (GDM) contributes substantially to the population burden of type 2 diabetes (T2DM), with a high long-term risk of developing T2DM. This study will assess whether a structured lifestyle modification programme for women immediately after a GDM pregnancy, delivered via customised text messages and further individualised using data from activity monitors, improves T2DM risk factors, namely weight, physical activity (PA) and diet. METHODS AND ANALYSIS: This multicentre randomised controlled trial will recruit 180 women with GDM attending Westmead, Campbelltown or Blacktown hospital services in Western Sydney. They will be randomised (1:1) on delivery to usual care with activity monitor (active control) or usual care plus activity monitor and customised education, motivation and support delivered via text messaging (intervention). The intervention will be customised based on breastfeeding status, and messages including their step count achievements to encourage PA. Messages on PA and healthy eating will encourage good lifestyle habits. The primary outcome of the study is healthy lifestyle composed of weight, dietary and PA outcomes, to be evaluated at 6 months. The secondary objectives include the primary objective components, body mass index, breastfeeding duration and frequency, postnatal depression, utilisation of the activity monitor, adherence to obtaining an oral glucose tolerance test post partum and the incidence of dysglycaemia at 12 months. Relative risks and their 95% CIs will be presented for the primary objective and the appropriate regression analysis, adjusting for the baseline outcome results, will be done for each outcome. ETHICS AND DISSEMINATION: Ethics approval has been received from the Western Sydney Local Health District Human Research Ethics Committee (2019/ETH13240). All patients will provide written informed consent. Study results will be disseminated via the usual channels including peer-reviewed publications and presentations at national and international conferences. TRIAL REGISTRATION NUMBER: ACTRN12620000615987; Pre-results.

Indexed as

Cell PhoneDiabetes, GestationalDiabetes Mellitus, Type 2Text MessagingFemaleHumansLife StyleMulticenter Studies as TopicPregnancyRandomized Controlled Trials as TopicSmartphonediabetes in pregnancygeneral diabetesnutrition & dieteticspreventive medicine

Identifiers

PMID34535488
PMCPMC8451310
OpenAlexW3200780366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.